Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis. (2020)
Attributed to:
Clinical Psychopharmacology of Depression
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1176/appi.focus.18204
PubMed Identifier: 33343239
Publication URI: http://europepmc.org/abstract/MED/33343239
Type: Journal Article/Review
Volume: 18
Parent Publication: Focus (American Psychiatric Publishing)
Issue: 2
ISSN: 1541-4094